0 items USD 0.00Search
- Did you mean
- biosimilar
Your search for "biosimilars" gave back 691 results.
Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The global Adalimumab Monoclonal Antibody Biosimilar market size is expected to reach $ 955.4 million by 2029, rising at a market growth of 12.0%...
Catalog:
GIR
June 2023
Price: USD 4,480.00
Etanercept is a medication used to manage and treat autoimmune conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis,...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Avastin (Bevacizumab) is a medication used to treat a number of types of cancers and a specific eye disease. For cancer, it is given by slow...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
The global Neulasta (Pegfilgrastim) and Biosimilar market size is expected to reach $ 3816.3 million by 2029, rising at a market growth of 6.2% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
Adalimumab is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. The global...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Rituxan (Rituximab) and Biosimilar market size is expected to reach $ 5345.4 million by 2029, rising at a market growth of 3.3% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Remicade (Infliximab) and Biosimilar market size is expected to reach $ 3781.3 million by 2029, rising at a market growth of 5.4% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
Pegfilgrastim, sold under the brand name Neulasta among others, is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
THYROGEN (thyrotropin alfa for injection) contains recombinant human thyroid stimulating hormone (TSH). Thyrotropin alfa is synthesized in a...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Bevacizumab Monoclonal Antibody Biosimilar market size is expected to reach $ 484.9 million by 2029, rising at a market growth of -13.9%...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Adalimumab (Humira) and Biosimilar market size is expected to reach $ 16210 million by 2029, rising at a market growth of -4.9% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
RITUXAN® (rituximab) is a prescription medicine used to treat: Adults with Non-Hodgkin's Lymphoma (NHL): alone or with other chemotherapy...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Biosimilar is a biologic medical product which is highly similar to another already approved biological medicine. The global Adalimumab, Infliximab...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
